Abstract:In situ-gel-forming thermoresponsive copolymers have been widely exploited in controlled delivery applications because their critical gel temperature is similar to human body temperature. However, there are limitations to controlling the delivery of biologics from a hydrogel network because of the poor networking and reinforcement between the copolymer networks. This study developed an in situ-forming robust injectable and 3D printable hydrogel network based on cellulose nanocrystals (CNCs) incorporated amphiphilic copolymers, poly(ε-caprolactone-co-lactide)-b-poly(ethylene glycol)-b-poly(ε-caprolactone-co-lactide (PCLA). In addition, the physicochemical and mechanical properties of injectable hydrogels were controlled by physically incorporating CNCs with amphiphilic PCLA copolymers. CNCs played an unprecedented role in physically reinforcing the PCLA copolymers' micelle network via intermicellar bridges. Apart from that, the free-flowing closely packed rod-like CNCs incorporated PCLA micelle networks at low temperature transformed to a stable viscoelastic hydrogel network at physiological temperature. CNC incorporated PCLA copolymer sols effectively coordinated with hydrophobic doxorubicin and water-soluble lysozyme by a combination of hydrophobic and hydrogen bonding interaction and controlled the release of biologics. As shown by the 3D printing results, the biocompatible PCLA hydrogels continuously extruded during printing had good injectability and maintained high shape fidelity after printing without any secondary cross-linking steps. The interlayer bonding between the printed layers was high and formed stable 3D structures up to 10 layers. Subcutaneous injection of free-flowing CNC incorporated PCLA copolymer sols to BALB/c mice formed a hydrogel instantly and showed controlled biodegradation of the hydrogel depot without induction of toxicity at the implantation sites or surrounding tissues. At the same time, the in vivo antitumor effect on the MDA-MB-231 tumor xenograft model demonstrated that DOX-loaded hydrogel formulation significantly inhibited the tumor growth. In summary, the CNC incorporated biodegradable hydrogels developed in this study exhibit a prolonged release with special release kinetics for hydrophobic and hydrophilic biologics.

3D Printing and Coating to Fabricate a Hollow Bullet-Shaped Implant with Porous Surface for Controlled Cytoxan Release

Fabrication of Patterned Three-Dimensional Micron Scaled Core-Sheath Architectures for Drug Patches

Three-Dimensional Electrohydrodynamic Printing and Spinning of Flexible Composite Structures for Oral Multidrug Forms

3D Tumer Cell System for in Vitro Screening of Chemotherapeutic Drugs

E-jet 3D Printed Drug Delivery Implants to Inhibit Growth and Metastasis of Orthotopic Breast Cancer.

Implant Development Using 3D Printing with Polylactic Acid-Based Polymer

Electrostatic Self-Assembly of Multilayer Copolymeric Membranes on the Surface of Porous Tantalum Implants for Sustained Release of Doxorubicin

Implantable 3D Printed Hydrogel Scaffolds Loading Copper-Doxorubicin Complexes for Postoperative Chemo/Chemodynamic Therapy

A Highly Efficient, Low-Toxic, Wide-Spectrum Antibacterial Coating Designed for 3D Printed Implants with Tailorable Release Properties.

A Refined Hot Melt Printing Technique with Real-Time CT Imaging Capability.

Experimental Study of a Rifampicine-isoniazidcontrolled Release Drug Implant

An Ultrasound-Controllable Release System Based on Waterborne Polyurethane/chitosan Membrane for Implantable Enhanced Anticancer Therapy.

Integration Of An Anti-Tumor Drug Into Nanocrystalline Assemblies For Sustained Drug Release

A 3D-printed PCL/PEI/DNA bioactive scaffold for chemotherapy drug capture in vivo

Cellulose Nanocrystals-Incorporated Thermosensitive Hydrogel for Controlled Release, 3D Printing, and Breast Cancer Treatment Applications.

3D Printing of Bioinspired Compartmentalized Capsular Structure for Controlled Drug Release

Design, Modeling and 3D Printing of a Personalized Cervix Tissue Implant with Protein Release Function.

Fabrication of biodegradable hollow microsphere composites made of polybutylene adipate co-terephthalate/polyvinylpyrrolidone for drug delivery and sustained release

Fabrication of an Injectable Star-polylactide/Thiolated Hyaluronate Hydrogel as a Double Drug-Delivery System for Cancer Treatment

Study of Manipulative In Situ Pore-Formation upon Polymeric Coating on Cylindrical Substrate for Sustained Drug Delivery

Poly(caprolactone)-Based Coatings on 3D-Printed Biodegradable Implants: A Novel Strategy to Prolong Delivery of Hydrophilic Drugs